Overactive bladder drugs on AARP Medicare Rx Saver from UHC (S5921-376)
Oxybutynin, solifenacin, Myrbetriq and Gemtesa, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), California
- Premium
- $109.40/month
- Deductible
- $615.00
3 of 7 Overactive bladder drugs are covered on this plan. 2 of them require prior authorization.
4 aren't on the formulary, including Myrbetriq and mirabegron.
- $7.00Tier 2
- from $2.50Tier 4
- 17%Tier 3
Not on the formulary
Myrbetriq, mirabegron, tolterodine, trospium
Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.